Deciphera Pharmaceuticals, Inc. announced that it has appointed Matthew L. Sherman, M.D. as Executive Vice President and Chief Medical Officer. Dr. Sherman brings over 25 years of experience as a physician-scientist in clinical drug development in oncology and hematology at leading biotechnology and pharmaceutical companies. Dr. Sherman will be responsible for leading the clinical development and medical affairs strategy for the Company’s pipeline of small molecule drug candidates designed using its proprietary kinase switch control inhibitor platform.